Virogen Corporation Activates $500,000/Yr. Minimum Contract With Vet Cure Pharma of Pakistan

MINNEAPOLIS, MN--(Marketwire - September 08, 2008) - Virogen, Inc. (PINKSHEETS: VRGI), the developer and patent holder of a revolutionary vaccine to combat Newcastle disease, a deadly disease that kills chickens worldwide, announced that a contract has been activated with Vet Cure Pharma of Pakistan calling for revenue of $500,000 per annum. As anticipated, this contract follows shortly after receipt of VRGI's European Union (EU) manufacturing approval and licensing.